In a head-to-head trial, Eli Lilly's Zepbound, containing tirzepatide, showed 47% more weight loss compared to Novo Nordisk's Wegovy, containing semaglutide. Both drugs are effective for weight loss with similar side effects.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
